Food and pharmaceutical composition for treatment of fatty liver and inflammation by relieving endoplasmic reticulum stress
AssigneePICOENTECH Co., LTD.
InventorHung Taeck KWON
Life of this patent
Estimating the term…
Abstract
Food and pharmaceutical compositions that alleviate endoplasmic reticulum stress and thereby suppress or prevent various diseases caused by endoplasmic reticulum stress. is the embodiments are related to food and pharmaceutical compositions for the prevention or treatment of fatty liver symptoms or hepatitis, containing a lysate of any one or a mixture thereof selected from Saccharomyces cerevisiae KCTC13925BP, KCTC14122BP, KCTC14123BP, KCTC14983BP, KCTC14984BP, and KCTC14985BP.
Claims5
A composition for alleviating endoplasmic reticulum stress, containing any one or a mixture thereof selected from the group consisting of Saccharomyces cerevisiae KCTC13925BP, KCTC14122BP, KCTC14123BP, KCTC14983BP, KCTC14984BP, and KCTC14985BP.
A food composition for inhibiting fatty liver disease containing any one or a mixture thereof selected from the group consisting of Saccharomyces cerevisiae KCTC13925BP, KCTC14122BP, KCTC14123BP, KCTC14983BP, KCTC14984BP, and KCTC14985BP.
A pharmaceutical composition for preventing or treating fatty liver symptoms containing any one or a mixture thereof selected from the group consisting of Saccharomyces cerevisiae KCTC13925BP, KCTC14122BP, KCTC14123BP, KCTC14983BP, KCTC14984BP, and KCTC14985BP.
A hepatitis prevention food composition containing any one or a mixture thereof selected from the group consisting of Saccharomyces cerevisiae KCTC13925BP, KCTC14122BP, KCTC14123BP, KCTC14983BP, KCTC14984BP, and KCTC14985BP.
A hepatitis treatment composition containing any one or a mixture thereof selected from the group consisting of Saccharomyces cerevisiae KCTC13925BP, KCTC14122BP, KCTC14123BP, KCTC14983BP, KCTC14984BP, and KCTC14985BP.
Dependencies are inferred from the claim text.